A cost analysis of producing vaccines in developing countries

Keyphrases

• Developing Countries 100%
• Cost Analysis 100%
• Vaccine Production 45%
• Country Market 36%
• Developed Countries 27%
• Production Scale 27%
• Vaccine Price 18%
• Production Cost 18%
• Manufacturing Facility 18%
• Developing Countries Vaccine Manufacturers 18%
• Operating Cost 9%
• Immunization Programs 9%
• Dose-ranging 9%
• Economic Viability 9%
• Sustainable Production 9%
• Vaccine Cost 9%
• Variable Costs 9%
• Vaccine Formulation 9%
• Economies of Scope 9%
• Economies of Scale 9%
• Potential Profit 9%
• Cost of Capital 9%
• Fixed Costs 9%
• Reliable Assessments 9%
• Vaccine Types 9%
• Producer Surplus 9%
• Local Production 9%